Participants
Contact
The press reports on the research done at IRB by Angel R. Nebreda, ICREA research professor and BBVA Foundation Cancer Research Professor. Nebreda’s lab has discovered an essential regulator of colorectal cancer, the protein p38, and proposes that inhibitors against this protein that might slow down tumor development.
Read the news
Related News
28 March 2014
Nebreda: "Our advantage is that p38 inhibitors are now available"
27 March 2014
Researchers at IRB discover a key regulator of colon cancer
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
